Stocks powered higher Thursday, with the Dow Jones Industrial Average reclaiming the 50,000 mark and both the S&P 500 and Nasdaq charging to fresh record highs as enthusiasm around artificial intelligence stocks roared back into the market.
The Dow climbed 370 points, or 0.8%, to finish at 50,063, while the S&P 500 added 57 points, also up 0.8%, to close at 7,501. The tech-heavy Nasdaq gained 233 points, or 0.9%, ending the session at 26,635.
Snail Inc (NASDAQ:SNAL) stormed back to profitability in the first quarter, posting results that blew past analyst estimates and sending shares up roughly 156% on Thursday as investors bet on a crowded content pipeline stretching through the rest of the year.
The numbers behind the move were hard to ignore. Net revenues climbed 35.7% to $27.3 million for the three months ended March 31, up from $20.1 million a year earlier, driven by strong sales of ARK: Survival Ascended and the breakout performance of medieval survival game Bellwright. Net income swung to $2.1 million from a net loss of $1.9 million in the same period last year, a gain of roughly 210% year over year.
Snail Inc (NASDAQ:SNAL) announced that it attended Gamescom LATAM as the company looks to expand partnerships and publishing opportunities in Latin America, a region it described as an increasingly important market for the global gaming industry.
The Culver City, California-based gaming company said the event’s attendance rose 17.5% in 2026, underscoring growing interest in the Latin American games sector.
G Mining Ventures Corp (TSX:GMIN, OTCQX:GMINF, FRA:W97) is expected to see a stronger second half in 2026, with Jefferies pointing to a back-end weighted production profile and advancing development work at its key projects as the company maintains guidance despite a softer start to the year.
The company reiterated its 2026 production outlook of 160,000 to 190,000 ounces of gold, with roughly 62% of output expected in the second half as higher-grade mineralization becomes accessible. Jefferies noted this weighting, alongside stable cost guidance, as a key support to the outlook despite near-term pressure from realized pricing dynamics under its Franco-Nevada streaming agreement.
Power Metallic Mines Inc (TSX-V:PNPN, FRA:IVV1, OTCQB:PNPNF) has had its “Outperform” rating and $2.65 price target reiterated by Noble Capital Markets following the company’s partnership announcement with Ideon Technologies to deploy muon tomography at its Lion Zone discovery within the Nisk polymetallic project in Quebec.
Noble’s price target implies significant upside from Power Metallic’s current share price of $1.46.
Arianne Phosphate Inc (TSX-V:DAN, OTCQB:DRRSF) said on Thursday it has successfully produced phosphoric acid on a continuous basis from its high-purity phosphate concentrate, marking the first time the process has been achieved in Quebec from a locally sourced apatite concentrate in more than 130 years.
The milestone involved producing roughly 1.5 tonnes of phosphoric acid over a one-week period at mineral processing research centre Corem's facilities.
Northstar Gold Corp. (CSE:NSG) announced that it is advancing exploration and development work at its 100%-owned Miller copper-gold property, located approximately 18 kilometres southeast of Kirkland Lake, Ontario, while outlining plans for renewed drilling at the Allied Gold Zone and continued advancement of its Cam Copper initiative.
The company said it is continuing work on the high-grade Cam Copper volcanogenic massive sulphide project and associated Surgical Mining initiatives in collaboration with Novamera, while also preparing to resume expansion drilling at the nearby Allied Gold Zone later this year.
Ideal Power Inc (NASDAQ:IPWR, FRA:5ILA) is positioning its patented B-TRAN bidirectional semiconductor switch at the center of a major industry shift toward high-voltage DC power architectures, the company said Thursday.
The news came as the Austin, Texas-based company reported first quarter results that reflected accelerating commercial momentum.
VivoPower PLC (NASDAQ:VIVO, FRA:51J) said on Thursday that its chief investment officer Alex Cuppage will speak at KBRA’s European Data Centers Event in London later this month, where discussions are expected to focus on AI infrastructure financing and power access challenges facing the sector.
According to VivoPower, the presentation will center on the company’s sovereign AI compute infrastructure strategy and the expansion of its “Power-to-X” platform, which involves the development, ownership and leasing of powered land and data center assets intended for AI compute applications.
NextSource Materials Inc. (TSX:NEXT, OTCQB:NSRCF) received a delegation from Germany's Federal Institute for Geosciences and Natural Resources this week at its Molo Graphite Mine in southern Madagascar.
The BGR, as the institute is known, assessed Molo as part of an independent study on Madagascar's graphite production sector funded by Germany's Federal Ministry for Economic Cooperation and Development, NextSource said in a statement.
Phunware Inc (NASDAQ:PHUN, FRA:2RJA) said Thursday it has appointed Dmitry Kroshka as CEO and brought in a product consultancy led by a former Disney+ executive to accelerate a strategic update of its mobile guest intelligence platform.
Kroshka, who has served as a senior advisor to the company since October 2025, will lead what Phunware is calling its "2.0 Strategy," focused on converting the company's mobile, location-aware, and customer engagement capabilities into a unified, AI-enabled platform for large-property operators in hospitality, healthcare, and adjacent markets.
Tiziana Life Sciences Ltd (NASDAQ:TLSA) reported PET imaging results from two patients in a Phase 2 Multiple System Atrophy trial showing up to 35% and 24% reductions in brain inflammation markers following intranasal foralumab treatment.
The reductions were observed in areas including the basal ganglia and cerebellar white matter, regions known to be involved in the neurodegenerative processes underlying MSA, a rare, progressive disorder for which no approved disease-modifying treatments currently exist.
BioHarvest Sciences Inc (NASDAQ:BHST, FRA:8MV0) reported an 8% jump in first quarter revenue as the company advanced several contract development and manufacturing organization (CDMO) projects and expanded its direct-to-consumer wellness business.
The company posted first quarter revenue of $8.5 million, up from $7.9 million a year earlier, while maintaining its full-year revenue guidance range of $42 million to $48 million. Gross margin improved slightly to 59% from 58% in the prior-year quarter.
G Mining Ventures Corp (TSX:GMIN, OTCQX:GMINF, FRA:W97) posted record operating margins in the first quarter of 2026, fuelled by surging gold prices, as it advances its Oko West project in Guyana.
The company, which operates the Tocantinzinho mine in Brazil, posted net income of $80.4 million, or $0.35 per share, in the three months ended March 31, up from $24.4 million in the same period a year earlier.
OptiBiotix Health PLC (AIM:OPTI, OTCQB:OPTBF), the AIM-listed life sciences company developing gut microbiome products and healthy sugar substitutes, saw its shares jump 13.5% to 5.68p after announcing plans to demonstrate its SweetBiotix products to shareholders at a London event in June.
The company reported a breakthrough in the manufacture of SweetBiotix in November 2025, achieving higher yields of a purer, more concentrated and better-tasting product with lower ingredient and production costs.
Touchstone Exploration Inc (AIM:TXP, TSX:TXP, OTC:PBEGF) shares slumped, losing 19% to 7.5p, after it flagged near-term liquidity pressure and issued a going concern warning tied to debt covenants and funding needs.
It came, however, as the firm reported first-quarter production rose year-on-year, with average daily production up 8% to 4,657 barrels of oil equivalent per day, as output from the Central field helped offset natural declines across legacy assets.
Tamboran Resources Corporation (NYSE:TBN, ASX:TBN, OTC:TBNRL, FRA:O8R) says the March quarter marked another step forward in its Beetaloo Basin development strategy, with record well results, progress on key infrastructure and a strengthened balance sheet to support its 2026 and 2027 work programs.
“The March 2026 quarter represents another major step forward for Tamboran as we continue to execute our Beetaloo Basin strategy," Tamboran Resources Corporation CEO Todd Abbott said.
Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) has completed a further milestone under its BARDA-funded FebriDx® paediatric clinical study, enrolling 250 patients in the trial.
The achievement marks milestone number 7 under the company’s agreement with the Biomedical Advanced Research and Development Authority (BARDA), which is supporting the study of FebriDx in children aged 2 to 12 years.